CCR2 and breast ductal adenocarcinoma: Compared to cells expressing control shRNAs, CCR2-KD cells showed a 50% decrease in CCR2 expression, compared to cells expressing control shRNAs, corresponding to decreased formation of invasive ductal carcinomas in mice (Brummer et al., 2018).